| Literature DB >> 28702054 |
Valerie M Harvey1,2, Clinton W Enos1,2, Jarvis T Chen3, Hadiza Galadima4, Karl Eschbach5.
Abstract
BACKGROUND: Hispanics diagnosed with cutaneous melanoma are more likely to present at advanced stages but the reasons for this are unknown. We identify census tracts at high risk for late stage melanoma diagnosis (LSMD) and examine the contextual predictors of LSMD in California, Texas, and Florida.Entities:
Year: 2017 PMID: 28702054 PMCID: PMC5494113 DOI: 10.1155/2017/8418904
Source DB: PubMed Journal: J Cancer Epidemiol ISSN: 1687-8558
Distribution of patient cases by summary stage, California, Texas, and Florida, 1996–2012.
| Summary stage at diagnosis | California | Texas | Florida | Category | |||
|---|---|---|---|---|---|---|---|
| Frequency | % | Frequency | % | Frequency | % | ||
|
| 875 | 29.44 | 2123 | 42.35 | 1925 | 42.64 |
|
|
| 1385 | 46.60 | 1804 | 35.99 | 1785 | 39.53 | |
|
| |||||||
|
| 76 | 2.56 | 67 | 1.34 | 53 | 1.17 |
|
|
| 195 | 6.56 | 142 | 2.83 | 141 | 3.12 | |
|
| 47 | 1.58 | 36 | 0.72 | 28 | 0.62 | |
|
| 26 | 0.87 | 6 | 0.12 | 11 | 0.24 | |
|
| 225 | 7.57 | 189 | 3.77 | 153 | 3.39 | |
|
| 143 | 4.81 | 646 | 12.89 | 419 | 9.28 | |
Demographic and clinical characteristics of melanoma cases in Hispanic men by stage, California, Texas, and Florida, 1996–2012.
| California | Texas | Florida | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Early ( |
| Late ( | Early ( |
| Late ( | Early ( |
| Late ( | |
| Number (%) | Number (%) | Number (%) | Number (%) | Number (%) | Number (%) | ||||
|
| |||||||||
|
| 59.3 ± 17.2 | 0.0175 | 57.5 ± 18 | 60.6 ± 15.1 | 0.1554 | 59.9 ± 16.2 | 65.2 ± 26.4 | 0.0286 | 63.1 ± 16.4 |
|
| |||||||||
| 18–34 | 182 (8.1) | 0.1876 | 68 (9.6) | 207 (5.3) | 0.0153 | 75 (6.9) | 116 (3.1) | 0.0282 | 38 (4.7) |
| 35–49 | 480 (21.2) | 168 (23.6) | 716 (18.2) | 223 (20.5) | 502 (13.5) | 122 (15.2) | |||
| 50–64 | 630 (27.9) | 2192 (27.0) | 1338 (34.1) | 327 (30.1) | 1002 (27) | 226 (28.1) | |||
| 65 and older | 954 (42.2) | 274 (38.5) | 1667 (42.5) | 461 (42.5) | 2081 (56.1) | 414 (51.4) | |||
| Missing | 14 (0.6) | 10 (1.4) | 0 (0.0) | 0 (0.0) | 9 (0.2) | 5 (0.6) | |||
|
| |||||||||
| White | 2112 (93.5) | <0.0001 | 702 (98.6) | 2515 (64.0) | <0.0001 | 820 (75.5) | 1297 (35) | <0.0001 | 514 (63.9) |
| Black | 0 (0.0) | 2 (0.3) | 68 (1.7) | 79 (7.3) | 121 (3.3) | 104 (12.9) | |||
| Other | 2 (0.1) | 0 (0.0) | 100 (2.6) | 56 (5.2) | 197 (5.3) | 60 (7.5) | |||
| Unknown | 146 (6.5) | 8 (1.1) | 1244 (31.7) | 131 (12.1) | 2095 (56.5) | 127 (15.8) | |||
|
| |||||||||
| No insurance | 95 (4.2) | <0.0001 | 53 (7.4) | 53 (1.4) | <0.0001 | 51 (4.7) | 110 (3.0) | <0.0001 | 63 (7.8) |
| Private insurance | 1236 (54.7) | 298 (41.9) | 258 (6.6) | 106 (9.8) | 1291 (34.8) | 262 (32.6) | |||
| Medicaid | 117 (5.2) | 117 (16.4) | 8 (0.2) | 19 (1.8) | 50 (1.4) | 43 (5.3) | |||
| Medicare | 503 (22.3) | 172 (24.2) | 205 (5.2) | 113 (10.4) | 1218 (32.8) | 272 (33.8) | |||
| Other | 27 (1.2) | 15 (2.1) | 55 (1.4) | 7 (0.6) | 43 (1.2) | 11 (1.4) | |||
| Unknown | 282 (12.5) | 57 (8.0) | 1800 (45.8) | 317 (29.2) | 998 (26.9) | 154 (19.1) | |||
| Missing | 0 (0.0) | 0 (0.0) | 1548 (39.4) | 473 (43.6) | 0 (0.0) | 0 (0.0) | |||
|
| |||||||||
|
| |||||||||
|
| |||||||||
| Head and neck | 833 (37) | <0.0001 | 119 (16.7) | 1383 (35.3) | <0.0001 | 245 (22.6) | 1190 (32) | <0.0001 | 161 (20.1) |
| Trunk | 660 (29.2) | 126 (17.7) | 1194 (30.4) | 253 (23.3) | 1257 (33.9) | 198 (24.6) | |||
| Upper extremity | 384 (17.0) | 93 (13.1) | 888 (22.6) | 162 (14.9) | 865 (23.3) | 108 (13.4) | |||
| Lower extremity | 370 (16.4) | 195 (27.4) | 385 (9.8) | 215 (19.8) | 371 (10) | 146 (18.1) | |||
| Overlap | 1 (0.0) | 0 (0.0) | 6 (0.2) | 4 (0.4) | 2 (0.1) | 1 (0.1) | |||
| Unknown | 12 (0.5) | 179 (25.1) | 71 (1.8) | 207 (19.1) | 25 (0.7) | 191 (23.7) | |||
|
| |||||||||
| T0 | 11 (0.5) | <0.0001 | 68 (9.6) | 17 (0.4) | <0.0001 | 13 (1.2) | 19 (0.5) | <0.0001 | 22 (2.7) |
| T1 | 794 (35.1) | 59 (8.3) | 630 (16.0) | 113 (10.4) | 776 (20.9) | 82 (10.2) | |||
| T2 | 274 (12.1) | 65 (9.1) | 40 (1.0) | 13 (1.2) | 115 (3.1) | 21 (2.6) | |||
| T3 | 157 (7.0) | 98 (13.8) | 17 (0.4) | 13 (1.2) | 69 (1.9) | 30 (3.7) | |||
| T4 | 76 (3.4) | 128 (18.0) | 18 (0.5) | 19 (1.8) | 40 (1.1) | 42 (5.2) | |||
| 9.80 mm or larger | 5 (0.2) | 33 (4.6) | 4 (0.1) | 8 (0.7) | 7 (0.2) | 20 (2.5) | |||
| Unknown | 943 (41.7) | 261 (36.7) | 2468 (62.9) | 716 (65.9) | 1496 (40.3) | 263 (32.7) | |||
| Missing | 0 (0.0) | 0 (0.0) | 733 (18.7) | 191 (17.6) | 1188 (32) | 325 (40.4) | |||
|
| |||||||||
| No ulceration present | 1201 (53.1) | <0.0001 | 172 (24.2) | 754 (19.2) | <0.0001 | 48 (4.4) | 1470 (39.6) | <0.0001 | 109 (13.5) |
| Ulceration present | 137 (6.1) | 141 (19.8) | 48 (1.2) | 22 (3.0) | 107 (2.9) | 83 (10.3) | |||
| Not collected, unknown, and missing | 922 (40.8) | 399 (56) | 3125 (79.6) | 1005 (92.6) | 2133 (57.5) | 613 (76.2) | |||
|
| |||||||||
| No lymph node metastases | 1368 (60.5) | 116 (16.3) | 947 (24.1) | 48 (4.4) | 2381 (64.2) | 115 (14.3) | |||
| Clinically positive lymph nodes and/or in-transit metastasis | 2 (0.1) | <0.0001 | 184 (25.9) | — | <0.0001 | 59 (5.4) | 1 (0.0) | <0.0001 | 119 (14.8) |
| Information not collected, unknown, and missing | 890 (39.4) | 412 (57.9) | 2980 (75.9) | 979 (90.2) | 1328 (35.8) | 571 (71) | |||
|
| |||||||||
| Surgery was performed | 2138 (94.6) | <0.0001 | 483 (67.8) | 2320 (59.1) | <0.0001 | 598 (55.1) | 3335 (89.9) | <0.0001 | 577 (71.7) |
| Surgery not performed | 83 (3.7) | 203 (28.5) | 67 (1.7) | 118 (10.9) | 344 (9.3) | 179 (22.2) | |||
| Recommended, not given, refused, unknown if performed, patient died prior to surgery, or surgery contraindicate due to patient risk factors | 30 (1.3) | 10 (1.4) | 16 (0.4) | 21 (2.0) | 15 (0.5) | 8 (1.1) | |||
| Unknown, diagnosed at autopsy, or death certificate only | 9 (0.4) | 8 (1.1) | 822 (20.9) | 240 (22.1) | 16 (0.4) | 41 (5.1) | |||
| Missing | 0 (0.0) | 0 (0.0) | 702 (17.9) | 109 (10) | — | — | |||
|
| |||||||||
| Histology, including hematology | 2260 (100.0) | <0.0001 | 683 (95.9) | 3923 (99.9) | <0.0001 | 993 (91.4) | 3704 (99.8) | <0.0001 | 762 (94.7) |
| Other | 0 (0.0) | 29 (4.1) | 4 (0.1) | 93 (8.6) | 6 (0.2) | 43 (5.3) | |||
|
| |||||||||
| Melanoma NOS | 1199 (53.1) | <0.0001 | 481 (67.6) | 2432 (61.9) | <0.0001 | 722 (66.5) | 2899 (77.9) | <0.0001 | 646 (80.3) |
| Nodular | 125 (5.5) | 128 (18.0) | 89 (2.3) | 66 (6.1) | 97 (2.6) | 66 (8.2) | |||
| Lentigo maligna | 371 (16.4) | 2 (0.3) | 544 (13.9) | 88 (8.1) | 334 (9.0) | 7 (0.9) | |||
| Superficial spreading | 471 (20.8) | 53 (7.4) | 753 (19.2) | 119 (11) | 269 (7.3) | 22 (2.7) | |||
| Acral lentiginous | 94 (4.2) | 48 (6.7) | 56 (1.4) | 53 (4.9) | 50 (1.4) | 27 (3.4) | |||
| Other | — | — | 53 (1.4) | 38 (3.6) | 71 (2.0) | 37 (4.6) | |||
Other forms of diagnostic confirmation: cytology, microscopically confirmed, but type of specimen unknown, positive lab test or marker study, direct observation, radiography, clinical, and other. Other histologic types with corresponding histology codes: balloon cell melanoma (8722); malignant melanoma regressing (8723); amelanotic melanoma (8730); melanoma in junctional nevus (8740); melanoma in precancerous melanosis (8741); desmoplastic melanoma (8745); mucosal lentiginous melanoma (8746); melan giant pig nevus (8761); epithelioid/spindle cell melanoma (8770); epithelial cell melanoma (8771); spindle cell melanoma (8772); and blue nevus malignant (8780); P values are applied within each state to compare early and late stage disease.
Correlation matrix for tract level contextual variables by state.
| State | % of a tract's residents who are Hispanic | % of a tract's Hispanic residents who are foreign-born or born outside of the 50 states/DC | % of tract Hispanics who say they speak English not well or not at all | % of tract Hispanics living below the FPL | |
|---|---|---|---|---|---|
| California | % of a tract's Hispanic residents who are foreign-born or born outside of the 50 states/DC | 0.50 | |||
| % of tract Hispanics who say they speak English not well or not at all | 0.63 | 0.83 | |||
| % of tract Hispanics living below the FPL | 0.38 | 0.33 | 0.49 | ||
| Allocated primary care physicians that are clinically active (PCSA)/100,000 population | −0.38 | 0.06 | −0.10 | −0.18 | |
|
| |||||
| Texas | % of a tract's Hispanic residents who are foreign-born or born outside of the 50 states/DC | 0.07 | |||
| % of tract Hispanics who say they speak English not well or not at all | 0.34 | 0.82 | |||
| % of tract Hispanics living below the FPL | 0.42 | 0.23 | 0.45 | ||
| Allocated primary care physicians that are clinically active (PCSA)/100,000 population | −0.39 | −0.07 | −0.14 | −0.12 | |
|
| |||||
| Florida | % of a tract's Hispanic residents who are foreign-born or born outside of the 50 states/DC | 0.64 | |||
| % of tract Hispanics who say they speak English not well or not at all | 0.52 | 0.66 | |||
| % of tract Hispanics living below the FPL | −0.02 | 0.01 | 0.35 | ||
| Allocated primary care physicians that are clinically active (PCSA)/100,000 population | 0.34 | 0.38 | 0.21 | −0.06 | |
Based on data from the American Community Survey; FPL: federal poverty level.
Figure 1Spatial distribution of late stage diagnosis. ((a)–(c)) Each map depicts the prevalence of late stage melanoma diagnosis in Hispanic men in California, Texas, and Florida, respectively. Maps were generated using the Geographic Information System (GIS). All P values less than 0.05 were considered statistically significant.
Contextual characteristics of Hispanic men diagnosed with melanoma by stage in California, Texas, and Florida, 1996–2012.
| California | Texas | Florida | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Contextual variables | Early ( |
| Late ( | Early ( |
| Late ( | Early ( |
| Late ( |
| Number (%) | Number (%) | Number (%) | Number (%) | Number (%) | Number (%) | ||||
|
| |||||||||
|
| |||||||||
| 0–14.9% | 941 (41.6) | <0.0001 | 181 (25.4) | 2302 (58.6) | <0.0001 | 376 (34.6) | 2210 (59.6) | <0.0001 | 323 (40.1) |
| 15–24.9% | 382 (16.9) | 118 (16.6) | 752 (19.2) | 232 (21.4) | 749 (20.2) | 184 (22.9) | |||
| 25–39.9% | 415 (18.4) | 156 (21.9) | 502 (12.8) | 214 (19.7) | 426 (11.5) | 168 (20.9) | |||
| 40–100% | 435 (19.3) | 237 (33.3) | 315 (8.0) | 241 (22.2) | 166 (4.5) | 95 (11.8) | |||
| Missing | 87 (3.9) | 20 (2.8) | 56 (1.4) | 23 (2.1) | 159 (4.3) | 35 (4.4) | |||
|
| |||||||||
| <10% | 1072 (47.4) | <0.0001 | 242 (34.0) | 2109 (53.7) | <0.0001 | 349 (32.1) | 2076 (56.0) | <0.0001 | 315 (39.1) |
| 10–19.9% | 643 (28.5) | 227 (31.9) | 1087 (27.7) | 309 (28.5) | 1085 (29.3) | 267 (33.2) | |||
| ≥20% | 459 (20.3) | 220 (30.9) | 689 (17.6) | 408 (37.6) | 386 (10.4) | 190 (23.6) | |||
| Missing | 86 (3.8) | 23 (3.2) | 42 (1.1) | 20 (1.8) | 163 (4.4) | 33 (4.1) | |||
|
| |||||||||
| 7,594–$42,064 | 787 (34.8) | <0.0001 | 340 (47.8) | 853 (21.7) | <0.0001 | 424 (39.0) | 782 (21.1) | <0.0001 | 259 (32.2) |
| 42,065–$52,506 | 490 (21.7) | 165 (23.2) | 684 (17.4) | 224 (20.6) | 619 (17.4) | 132 (16.4) | |||
| 52,507–$65,310 | 391 (17.3) | 101 (14.2) | 678 (17.3) | 162 (14.9) | 670 (18.1) | 126 (15.7) | |||
| 65,311–$87,847 | 303 (13.4) | 50 (7.0) | 810 (20.6) | 143 (13.2) | 648 (17.5) | 111 (13.8) | |||
| 87,848–$244,876 | 213 (9.4) | 36 (5.1) | 872 (22.2) | 116 (10.7) | 837 (22.6) | 144 (17.9) | |||
| Missing | 76 (3.4) | 20 (2.8) | 30 (0.8) | 17 (1.6) | 154 (4.2) | 33 (4.1) | |||
|
| |||||||||
| Ethnic concentration measures | Early ( |
| Late ( | Early ( |
| Late ( | Early ( |
| Late ( |
| Number (%) | Number (%) | Number (%) | Number (%) | Number (%) | Number (%) | ||||
|
| |||||||||
|
| |||||||||
| 0–3 | 304 (13.5) | <0.0001 | 54 (7.58) | 870 (22.2) | <0.0001 | 148 (13.6) | 803 (21.6) | <0.0001 | 118 (14.7) |
| >3–10 | 467 (20.7) | 97 (13.6) | 1203 (30.6) | 257 (23.7) | 684 (18.4) | 98 (12.2) | |||
| >10–25 | 821 (36.3) | 276 (38.8) | 1276 (32.5) | 417 (38.4) | 1171 (31.6) | 262 (32.6) | |||
| >25 | 592 (26.2) | 265 (37.2) | 545 (13.9) | 246 (22.7) | 851 (22.9) | 295 (36.7) | |||
| Missing | 76 (3.4) | 20 (2.8) | 33 (0.8) | 18 (1.7) | 201 (5.4) | 32 (4.0) | |||
|
| |||||||||
| <25 | 483 (21.4) | <0.0001 | 102 (14.3) | 1875 (47.8) | <0.0001 | 430 (39.6) | 201 (5.4) | <0.0001 | 29 (3.6) |
| >25–40 | 788 (34.9) | 224 (31.5) | 1232 (31.4) | 337 (31.0) | 432 (11.6) | 74 (9.2) | |||
| >40–65 | 882 (39.0) | 350 (49.2) | 74 (19.0) | 281 (25.9) | 1680 (45.3) | 302 (37.5) | |||
| >65 | 31 (1.4) | 16 (2.3) | 41 (1.0) | 20 (1.8) | 1196 (32.2) | 368 (45.7) | |||
| Missing | 76 (3.4) | 20 (2.8) | 32 (0.8) | 18.0 (1.7) | 201 (5.4) | 32 (4.0) | |||
|
| |||||||||
| 0–20 | 763 (33.8) | <0.0001 | 134 (18.8) | 2103 (53.6) | <0.0001 | 393 (36.2) | 2270 (61.2) | <0.0001 | 346 (43.0) |
| >20–40 | 514 (22.7) | 129 (18.1) | 866 (22.1) | 210 (19.3) | 542 (14.6) | 144 (17.9) | |||
| >40–60 | 349 (15.4) | 134 (18.8) | 383 (9.8) | 131 (12.1) | 277 (7.5) | 72 (8.9) | |||
| >60 | 559 (24.7) | 296 (41.6) | 546 (13.9) | 335 (30.9) | 472 (12.7) | 215 (26.7) | |||
| Missing | 75 (3.3) | 19 (2.8) | 29 (0.7) | 17 (1.6) | 149 (4.0) | 28 (3.5) | |||
|
| |||||||||
| Healthcare resource allocation | Early ( |
| Late ( | Early ( |
| Late ( | Early ( |
| Late ( |
| Number (%) | Number (%) | Number (%) | Number (%) | Number (%) | Number (%) | ||||
|
| |||||||||
|
| |||||||||
| <57 | 411 (18.2) | <0.0001 | 172 (24.2) | 1207 (30.7) | <0.0001 | 482 (44.4) | 601 (16.2) | 0.1378 | 126 (15.6) |
| 57–82 | 998 (44.2) | 356 (50.0) | 2013 (51.3) | 473 (43.6) | 2147 (57.9) | 498 (61.9) | |||
| >82 | 776 (34.3) | 165 (23.2) | 679 (17.3) | 115 (10.6) | 814 (21.9) | 157 (19.5) | |||
| Missing | 75 (3.3) | 19 (2.7) | 28 (0.7) | 16 (1.5) | 148 (4.0) | 24 (3.0) | |||
|
| |||||||||
| Not a MUA/P | 1718 (76.0) | <0.0001 | 19 (2.7) | 2483 (63.2) | <0.0001 | 572 (52.7) | 1886 (50.8) | <0.0001 | 367 (45.6) |
| Med. unders. area | 332 (14.7) | 494 (69.4) | 1371 (34.9) | 467 (43.0) | 1184 (31.9) | 201 (25.0) | |||
| Med. unders. pop. | 135 (6.0) | 143 (20.1) | 45 (1.2) | 31 (2.9) | 496 (13.4) | 213 (26.5) | |||
| Missing | 75 (3.3) | 56 (7.9) | 28 (0.7) | 16 (1.5) | 144 (3.9) | 24 (3.0) | |||
HSS = high school.
Odds ratios for late melanoma diagnosis and census tract contextual variables among Hispanic men, California, Texas, and Florida, 1996–2012.
| California | Texas | Florida | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Minimally unadjusted | Fully adjusted | Minimally unadjusted | Fully adjusted | Minimally unadjusted | Fully adjusted ( | |||||||||||||
| Odds ratio estimates | 95% confidence limits | Odds ratio estimates | 95% confidence limits | Odds ratio estimates | 95% confidence limits | Odds ratio estimates | 95% confidence limits | Odds ratio estimates | 95% confidence limits | Odds ratio estimates | 95% confidence limits | |||||||
|
| ||||||||||||||||||
| 18–34 | 1.3 | 0.9 | 1.8 | 1.3 | 0.9 | 1.8 | 1.5 | 1.1 | 2.0 | 1.6 | 1.2 | 2.2 | 1.5 | 1.0 | 2.2 | 1.6 | 1.0 | 2.3 |
| 35–49 | 1.3 | 1.0 | 1.6 | 1.2 | 1.0 | 1.5 | 1.2 | 1.0 | 1.5 | 1.3 | 1.1 | 1.6 | 1.2 | 0.9 | 1.5 | 1.2 | 1.0 | 1.6 |
| 50–64 | 1.1 | 0.9 | 1.3 | 1.0 | 0.8 | 1.2 | 0.9 | 0.8 | 1.1 | 1.0 | 0.9 | 1.2 | 1.1 | 0.9 | 1.3 | 1.1 | 0.9 | 1.3 |
| ≥65 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
|
| ||||||||||||||||||
| 0–14.9% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| 15–24.9% | 1.6 | 1.2 | 2.1 | 1.3 | 0.8 | 1.5 | 1.9 | 1.5 | 2.3 | 1.6 | 1.3 | 2.1 | 1.7 | 1.3 | 2.1 | 1.4 | 1.1 | 1.8 |
| 25–39.9% | 1.9 | 1.5 | 2.4 | 1.2 | 0.6 | 1.3 | 2.5 | 2.0 | 3.1 | 1.8 | 1.3 | 2.4 | 2.5 | 1.9 | 3.1 | 1.7 | 1.3 | 2.4 |
| 40–100% | 2.7 | 2.1 | 3.4 | 1.0 | 0.6 | 1.6 | 4.2 | 3.3 | 5.2 | 2.5 | 1.7 | 3.8 | 3.4 | 2.4 | 4.7 | 1.8 | 1.2 | 2.8 |
|
| ||||||||||||||||||
| <10% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| 10–19.9% | 1.6 | 1.3 | 1.9 | 1.0 | 0.8 | 1.3 | 1.7 | 1.4 | 2.0 | 1.3 | 1.0 | 1.6 | 1.6 | 1.3 | 1.9 | 1.2 | 0.9 | 1.5 |
| ≥20% | 2.0 | 1.6 | 2.5 | 1.1 | 0.8 | 1.5 | 3.2 | 2.7 | 3.9 | 1.7 | 1.3 | 2.3 | 2.9 | 2.2 | 3.6 | 1.8 | 1.3 | 2.4 |
|
| ||||||||||||||||||
| 0–3 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| >3–10 | 1.1 | 0.8 | 1.6 | 0.9 | 0.6 | 1.3 | 1.3 | 1.0 | 1.6 | 1.0 | 0.8 | 1.3 | 1.0 | 0.7 | 1.3 | 0.9 | 0.7 | 1.2 |
| >10–25 | 1.8 | 1.3 | 2.5 | 1.0 | 0.7 | 1.6 | 1.7 | 1.4 | 2.1 | 0.9 | 0.7 | 1.2 | 1.4 | 1.1 | 1.8 | 1.0 | 0.8 | 1.4 |
| >25 | 2.3 | 1.7 | 3.3 | 0.9 | 0.6 | 1.6 | 2.3 | 1.8 | 2.9 | 0.7 | 0.5 | 1.0 | 2.0 | 1.5 | 2.6 | 0.8 | 0.6 | 1.1 |
|
| ||||||||||||||||||
| 0–20 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| >20–40 | 1.5 | 1.1 | 1.9 | 1.3 | 0.9 | 1.8 | 1.4 | 1.1 | 1.7 | 1.0 | 0.8 | 1.3 | 1.6 | 1.3 | 2.1 | 1.4 | 1.1 | 1.8 |
| >40–60 | 2.2 | 1.7 | 2.9 | 1.8 | 1.3 | 2.7 | 1.8 | 1.4 | 2.3 | 1.0 | 0.7 | 1.3 | 1.6 | 1.2 | 2.3 | 1.4 | 1.0 | 2.1 |
| >60 | 3.0 | 2.3 | 3.8 | 2.4 | 1.6 | 3.8 | 3.2 | 2.6 | 4.0 | 1.3 | 0.9 | 1.8 | 2.8 | 2.2 | 3.6 | 2.2 | 1.5 | 3.2 |
|
| ||||||||||||||||||
| <25 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| >25–40 | 1.3 | 1.0 | 1.7 | 1.0 | 0.8 | 1.4 | 1.0 | 0.8 | 1.2 | 0.9 | 0.8 | 1.1 | 1.1 | 0.7 | 1.8 | 1.1 | 0.7 | 1.8 |
| >40–65 | 1.9 | 1.5 | 2.5 | 1.3 | 0.9 | 1.8 | 1.5 | 1.2 | 1.8 | 1.4 | 1.1 | 1.8 | 1.2 | 0.8 | 1.8 | 1.1 | 0.7 | 1.7 |
| >65 | 2.9 | 1.5 | 5.6 | 2.3 | 1.1 | 4.7 | 2.1 | 1.2 | 3.7 | 2.2 | 1.2 | 4.0 | 1.8 | 1.1 | 2.7 | 1.3 | 0.8 | 2.1 |
|
| ||||||||||||||||||
| <57 | 1.9 | 1.4 | 2.5 | 1.4 | 1.0 | 1.9 | 2.2 | 1.7 | 2.9 | 1.6 | 1.3 | 2.1 | 1.1 | 0.8 | 1.5 | 1.0 | 0.8 | 1.4 |
| 57–82 | 1.6 | 1.3 | 2.0 | 1.4 | 1.1 | 1.8 | 1.5 | 1.2 | 1.9 | 1.2 | 1.0 | 1.6 | 1.1 | 0.8 | 1.4 | 1.0 | 0.8 | 1.3 |
| >82 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
|
| ||||||||||||||||||
| Not a MUA/P | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Med. unders. area | 1.5 | 1.2 | 2.0 | 1.1 | 0.8 | 1.4 | 1.6 | 1.4 | 2.0 | 0.9 | 0.7 | 1.1 | 0.9 | 0.7 | 1.2 | 0.8 | 0.6 | 1.1 |
| Med. unders. pop. | 1.4 | 1.0 | 2.0 | 1.1 | 0.8 | 1.6 | 2.2 | 1.3 | 3.7 | 1.3 | 0.7 | 2.1 | 2.0 | 1.6 | 2.6 | 1.2 | 0.9 | 1.6 |
|
| 1.0 | 0.9 | 1.0 | 0.9 | 0.9 | 1.0 | 0.9 | 0.9 | 1.0 | 0.9 | 0.9 | 1.0 | 1.0 | 1.0 | 1.0 | 0.9 | 0.9 | 1.0 |